Clinical Trial

Relationship Between Biomarkers and Heart Failure

Study Description

Biorepository Studying the Relationship Between Biomarkers and Heart Failure

This study aims to prospectively evaluate the relationship between serial measurement of several biomarkers, such as insulin-like growth factor binding protein 7 (IGFBP7), bone morphogenic protein 1 (BMP1), carboxyterminal propeptide of type-I procollagen (PICP), tissue inhibitor of metalloproteinases 1 (TIMP1) and matrix metallopeptidase 9 (MMP9), and echocardiographic features in three groups, including patients with heart failure with preserved ejection fraction (HFpEF), heart failure with reduced ejection fraction (HFrEF), and patients without a history of heart failure (HF). The relationship between these biomarkers and one year major adverse events will also be evaluated.


Locations Selected Location


No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Methods have not been listed for this study. If you require more information about the methods of this study, please inquire with the researcher.

Additional Information

Official Study Title

Preserved vs. Reduced Ejection Fraction Biomechanical Marker Registry for Ambulatory Heart Failure Patients (PREFER-HF)

Clinical Trial ID


ParticipAid ID